| Mrs Dana Ciobanu, DO | |
|
11815 Education St, Auburn, CA 95602-2410 | |
| (530) 886-6558 | |
| Not Available |
| Full Name | Mrs Dana Ciobanu |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 11815 Education St, Auburn, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003186644 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | R1721 (Texas) | Secondary |
| 207R00000X | Internal Medicine | 0000000 (New Jersey) | Secondary |
| 208M00000X | Hospitalist | 20A13523 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medical City Fort Worth | Fort worth, TX | Hospital |
| Medical City Weatherford | Weatherford, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Questcare Hospitalists Pllc | 5799785119 | 318 |
News Archive
This year's flu season is shaping up to be an especially serious one, and it's important for clinicians to promptly recognize, diagnosis, and treat influenza in hospitalized patients, especially in vulnerable populations such as older individuals.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.
Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).
IBM today announced a new fixed-price offering for small and mid-sized businesses (SMBs) navigating government compliance mandates for the United States pharmaceutical industry.
› Verified 5 days ago
| Entity Name | Questcare Hospitalists Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265441620 PECOS PAC ID: 5799785119 Enrollment ID: O20070109000581 |
News Archive
This year's flu season is shaping up to be an especially serious one, and it's important for clinicians to promptly recognize, diagnosis, and treat influenza in hospitalized patients, especially in vulnerable populations such as older individuals.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.
Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).
IBM today announced a new fixed-price offering for small and mid-sized businesses (SMBs) navigating government compliance mandates for the United States pharmaceutical industry.
› Verified 5 days ago
| Entity Name | Questcare Matrix Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740605492 PECOS PAC ID: 7719137397 Enrollment ID: O20121016000465 |
News Archive
This year's flu season is shaping up to be an especially serious one, and it's important for clinicians to promptly recognize, diagnosis, and treat influenza in hospitalized patients, especially in vulnerable populations such as older individuals.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.
Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).
IBM today announced a new fixed-price offering for small and mid-sized businesses (SMBs) navigating government compliance mandates for the United States pharmaceutical industry.
› Verified 5 days ago
| Entity Name | Acclaim Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780076562 PECOS PAC ID: 4587963582 Enrollment ID: O20160426000707 |
News Archive
This year's flu season is shaping up to be an especially serious one, and it's important for clinicians to promptly recognize, diagnosis, and treat influenza in hospitalized patients, especially in vulnerable populations such as older individuals.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.
Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).
IBM today announced a new fixed-price offering for small and mid-sized businesses (SMBs) navigating government compliance mandates for the United States pharmaceutical industry.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Dana Ciobanu, DO 10470 Old Placerville Rd, 100, Sacramento, CA 95827-2539 Ph: (800) 470-0071 | Mrs Dana Ciobanu, DO 11815 Education St, Auburn, CA 95602-2410 Ph: (530) 886-6558 |
News Archive
This year's flu season is shaping up to be an especially serious one, and it's important for clinicians to promptly recognize, diagnosis, and treat influenza in hospitalized patients, especially in vulnerable populations such as older individuals.
Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced financial results for the first quarter of fiscal year (FY) 2010 ended July 31, 2009. Total revenues for the first quarter of FY 2010 increased 345% to $6,750,000, compared to $1,517,000 for the comparable prior year quarter. This increase was primarily generated from increased government contract revenue and from increased sales by Avid Bioservices, the company's wholly owned contract manufacturing subsidiary.
Results of an Electronic Health Record (EHR) study assessing the most commonly used medications for raising blood pressure in patients with nontraumatic subarachnoid hemorrhage (SAH), a rare type of stroke, have been published in Neurosurgical Focus by scientists at The University of Texas Health Science Center at Houston (UTHealth).
IBM today announced a new fixed-price offering for small and mid-sized businesses (SMBs) navigating government compliance mandates for the United States pharmaceutical industry.
› Verified 5 days ago
Dr. Joshua James Crose, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 11815 Education St, Auburn, CA 95602 Phone: 530-886-6558 Fax: 530-889-6035 | |
Dr. Michelle Anne Fanoni, DO Hospitalist Medicare: Medicare Enrolled Practice Location: 11815 Education St, Auburn, CA 95602 Phone: 916-733-3777 |